Výsledky vyhledávání

Akademický článek

Efficacy and resistance of EGFR-TKIs for first-line treatment for compound EGFR mutations positive non-small cell lung cancer

Autor: GUAN Xuhui, LIN Xiaocheng, YANG Jinji

Publikováno v: 陆军军医大学学报, Vol 44, Iss 24, Pp 2486-2492 (2022)

Objective To observe the characteristics of mutation patterns in patients with compound EGFR mutations in the same exon and their resistance to EGFR TKIs, and to explore the clinical features and survival benefits among these non-small cell lung canc

Externí odkaz: https://doaj.org/article/29e3ab40c3234a469067d6bf8bdbc688

Zobrazit plný text záznamu

Report

Neural-FEBI: Accurate Function Identification in Ethereum Virtual Machine Bytecode

Autor: He, Jiahao, Li, Shuangyin, Wang, Xinming, Cheung, Shing-Chi, Zhao, Gansen, Yang, Jinji

Millions of smart contracts have been deployed onto the Ethereum platform, posing potential attack subjects. Therefore, analyzing contract binaries is vital since their sources are unavailable, involving identification comprising function entry ident

Externí odkaz: http://arxiv.org/abs/2301.12695

Zobrazit plný text záznamu

Akademický článek

Capillary reinforcement strategy guided construction of robust oxygen functionalized carbon-based porous foam for highly efficient solar evaporation

Autor: Zhang, Songdi, Liu, Mingyu, Yang, Jinji, Wang, Junjie, Fang, Zhiming, Bao, Chenlu

Publikováno v: In Separation and Purification Technology 19 February 2025 354 Part 7

Zobrazit plný text záznamu

Akademický článek

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

Autor: Zhang Xuchao, Zhang Shirley, Yang Xuening, Yang Jinji, Zhou Qing, Yin Lucy, An Shejuan, Lin Jiaying, Chen Shiliang, Xie Zhi, Zhu Mike, Zhang Xiaolin, Wu Yi-long

Publikováno v: Molecular Cancer, Vol 9, Iss 1, p 188 (2010)

Abstract Background The anaplastic lymphoma kinase (ALK) gene is frequently involved in translocations that lead to gene fusions in a variety of human malignancies, including lymphoma and lung cancer. Fusion partners of ALK include NPM, EML4, TPM3, A

Externí odkaz: https://doaj.org/article/ed24468ced994f80a34e48afa670a922

Zobrazit plný text záznamu